Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07647939 · ClinicalTrials.gov registry record · NA

Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study

A NA study, sponsored by Northwell Health.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT07647939 is a NA study that has not yet begun recruiting, run by Northwell Health. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07647939, a NA study, has not yet begun recruiting, sponsored by Northwell Health.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard CT scan for pulmonary embolism, can effectively detect blood clots in the left atrial appendage (LAA) in patients with atrial fibrillation. Detecting these clots is crucial before certain heart procedures to prevent stroke. Currently, a different, more involved procedure (Transesophageal Echocardiography - TEE) is often used. This study will assess if this additional CT scan is feasible, meaning if it can provide clear enough images to identify LAA clots without needing more contrast dye. The study will involve 60 patients, half receiving an "ungated" CT scan and the other half a "gated" CT scan (timed with their heart rhythm). The results of these scans will not be used for immediate patient care during the study, but rather to evaluate the CT scan technique itself. There is no direct benefit to participants, but the information gained could lead to faster diagnosis and reduced unnecessary testing for future patients.

Interventions

  • DEVICE Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus
  • DEVICE Delayed Gated CT Scan for Left Atrial Appendage Thrombus

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-07
Est. Completion 2027-06
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT07647939

The ClinicalTrials.gov registry entry for NCT07647939 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus is the first listed.

NCT07647939 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07647939 about?

NCT07647939 is a clinical study titled "Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study". This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard CT scan for pulmonary embolism, can effectively detect blood clots in the left atrial appendage (LAA) in patients with atrial fibrillation. Detecting these clots is crucial before ...

What is the current status of trial NCT07647939?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-07. Estimated completion is 2027-06.

What interventions are being tested in trial NCT07647939?

The interventions under investigation include: Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus (DEVICE), Delayed Gated CT Scan for Left Atrial Appendage Thrombus (DEVICE).

Who is sponsoring clinical trial NCT07647939?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.